Tiziana Life Sciences Ltd (TLSA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Operating Expenses | 15,794 | 17,984 | 14,586 | 27,374 | 28,026 |
| Operating Income | -15,794 | -17,984 | -14,586 | -27,374 | -28,026 |
| Interest Expense | -814 | -1,144 | 7 | 176 | 312 |
| Other Income | -1,766 | -402 | -804 | 893 | 0 |
| Pre-tax Income | -16,746 | -17,242 | -15,397 | -26,657 | -28,338 |
| Income Tax | -4,883 | 449 | N/A | -3,240 | -2,207 |
| Net Income Continuous | -11,863 | -17,691 | -15,397 | -23,417 | -26,131 |
| Net Income | $-11,863 | $-17,691 | $-15,397 | $-23,417 | $-26,131 |
| EPS Basic Total Ops | -0.11 | -0.17 | -0.15 | -0.24 | -0.27 |
| EPS Basic Continuous Ops | -0.11 | -0.17 | -0.15 | -0.24 | -0.27 |
| EPS Diluted Total Ops | -0.11 | -0.17 | -0.15 | -0.24 | -0.27 |
| EPS Diluted Continuous Ops | -0.11 | -0.17 | -0.15 | -0.24 | -0.27 |
| EPS Diluted Before Non-Recurring Items | -0.11 | -0.17 | -0.15 | -0.24 | -0.11 |
| EBITDA(a) | $-15,670 | $-17,888 | $-14,535 | $-27,233 | $-27,935 |